UPDATE: (NASDAQ:GOVX) has moved up 100% from this mornings trading surge. on 355,000 plus shares and increasing. Shares currently at $2.82 a share

(Nasdaq:GOVX) shares are up more than 18% this morning, on 19,000 plus trades at around $1.65 a share in the pre-market. Company is a vaccine play and has risen on recent news

GeoVax Announces Upcoming Presentations at Scientific Conferences

ATLANTA, GA, May 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire –GeoVax Labs, Inc. (Nasdaq:GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today that it will be represented during presentations at the following upcoming scientific conferences.

  • 2022 National Biotechnology Conference, Anaheim, CA, May 9-12

On May 11, Mary Hauser, PhD, GeoVax Director, Preclinical Research, will deliver a presentation titled, Strategic Prophylactics to Address Evolving SARS-CoV-2 Variants. Dr. Hauser will discuss the importance of T cell immunity to conserved viral epitopes amid the backdrop of rapid viral evolution.

  • Genetic Vaccine Development for Infectious Disease Summit, Boston, MA, May 24-26

On May 26, Don Diamond, PhD, professor in City of Hope’s Department of Hematology & Hematopoietic Transplantation, and the lead original developer of GeoVax’s vaccine against COVID-19 (GEO-CM04S1, formerly known as COH04S1) currently being evaluated in two Phase 2 clinical trials, will deliver a presentation titled, Conception, Construction, Pre-Clinical & Clinical Testing of COH04S1 Vaccine with Activity Against SARS-CoV-2.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.